St. Louis-based Monsanto Co. and Davis, Calif.-based AgraQuest have agreed to collaborate on potential uses of biopesticides Agraquest has in the pipeline as seed treatments for Monsanto's field and vegetable crops.
The three-year deal will focus on developing seed treatments to control nematoes, diseases and insects and to enhance plant growth and yield, according to a news release.
Any commercial product developed will complement Monsanto's Acceleron seed treatment line-up, which currently includes products for corn and soybeans.
As part of the arrangement, Monsanto will have exclusive rights to seed treatments for its core crops and vegetables, according to the release.
Monsanto also will have access to AgraQuest's library of Bacillus thuringiensus, or Bt, proteins for potential use as insecticides in biotech crops.
AgraQuest will retain rights to any developments for foliar and soil applications and for seed treatments in other crops.